Axine Signs Multimillion-Dollar Wastewater Service Agreement with a Global Pharmaceutical Company
Contract reinforces industry commitment to mitigate the impact of pharmaceuticals in the environment
VANCOUVER, BC,
Under terms of the agreement, Axine will design, build, own, and remotely operate a turnkey treatment system at an eastern
"This agreement is a significant milestone for Axine as we work to expand acceptance in the pharmaceutical industry," said
In recent years, the pharmaceutical industry has made progress in reducing APIs in wastewater discharged to the environment from manufacturing operations. While APIs are not currently regulated, policy initiatives are underway in
Axine has created a new standard for treating virtually any complex or challenging organic pollutant in pharmaceutical wastewater by combining breakthrough technology with a modular system and service business model. Systems are based on Axine's proprietary electrochemical oxidation technology, which uses advanced catalysts and electricity to oxidize and destroy a wide range of organic pollutants so the treated water can be safely discharged or reused.
Adds Rhone, "Our business model creates long-term partnerships with our customers while minimizing their capital investment and risk. By treating wastewater at the source and reusing the treated water where possible, we're also helping customers reduce both water consumption and environmental impacts in a cost-competitive manner."
The service agreement was signed after the completion of a comprehensive treatability test program conducted at Axine's
About
Axine has created a new standard for treating toxic organic pollutants in wastewater for customers in the pharmaceutical, chemical, and other industries to address a global problem. Axine's breakthrough solution combines advanced electrochemical oxidation technology with a flexible, modular system design capable of treating the widest range of organic pollutants with the highest performance and lowest cost. Axine's unique wastewater-as-a-service business model enables customers to achieve wastewater and sustainability goals with minimal capital investment and technology risk. For more information, please visit www.axinewater.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/axine-signs-multimillion-dollar-wastewater-service-agreement-with-a-global-pharmaceutical-company-301188859.html
SOURCE
Elsevier acquires Shadow Health, a leading provider of best-in-class healthcare simulations
Inspiration for Ruthie's Law forgotten by investor of nursing home where she died
Advisor News
- Advisors and consumers agree on need for retirement income planning
- For Americans, 2021 delivered healthiest finances in 8 years
- ‘Spring Cleaning’ Includes Your Client’s Finances, Too
- Retirement Savers Remain Confident Despite Short-Term Woes
- City of Memphis Helps Employees With Financial Wellness Programs
More Advisor NewsAnnuity News
Health/Employee Benefits News
- Medicaid-expansion bill clears two committees in the N.C. General Assembly. Work requirement may be a stumbling block.
- Pandemic, disparities, trust erosion challenge health care
- Health insurance case goes to Georgia Supreme Court
- Pennsylvania Bill For Continued CHIP Coverage Gains Committee Approval
- Oklahoma Medicaid managed care bill passes
More Health/Employee Benefits NewsLife Insurance
- Nationwide adds new index options to IUL Accumulator II 2020
- Finseca and NAILBA are officially merged
- Few players propelling huge private equity push into insurance
- NAIFA symposium provides insight, advice on engaging a more diverse client base
- NAIFA foundation will support the next generation of financial professionals
More Life Insurance